CD79A and neoplasm: Similarly, in immunohistochemistry, tumor cells express B‐cell markers (CD20, CD79α, PAX5), and most often exhibits a non‐germinal center phenotype (CD10−, MUM1+) along with high proliferation index (Ki‐67 > 80%) [5].